Zepbound (tirzepatide ... You will receive a combination of medication, meal plans, and behavioral tips to help you reach your goal weight. You will only be eligible for Noom Med if you have ...

For years, conventional wisdom has been that weight loss is a matter of willpower. Those who are overweight or obese just need to try harder to eat less and exercise more. But while diet and ...

Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales of popular weight-loss drug Zepbound after it last month forecast lower-than ...

The results of the first head-to-head trial of Lilly's dual GLP-1/GIP agonist Zepbound (tirzepatide ... which said it plans to present the data in full at a medical meeting next year.